These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 12675525

  • 1. Protease inhibitors prevent plasminogen-mediated, but not pemphigus vulgaris-induced, acantholysis in human epidermis.
    Schuh T, Besch R, Braungart E, Flaig MJ, Douwes K, Sander CA, Magdolen V, Probst C, Wosikowski K, Degitz K.
    Biol Chem; 2003 Feb; 384(2):311-5. PubMed ID: 12675525
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Complement fixation by pemphigus antibody. IV. Enhanced epidermal cell detachment in the absence of human plasminogen.
    Doubleday CW, Geoghegan WD, Jordon RE.
    J Lab Clin Med; 1988 Jan; 111(1):28-34. PubMed ID: 3335823
    [Abstract] [Full Text] [Related]

  • 4. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F.
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [Abstract] [Full Text] [Related]

  • 5. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity.
    Cirillo N, Gombos F, Lanza A.
    J Cell Physiol; 2007 Feb; 210(2):411-6. PubMed ID: 17058228
    [Abstract] [Full Text] [Related]

  • 6. Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG.
    Morioka S, Lazarus GS, Jensen PJ.
    J Invest Dermatol; 1987 Nov; 89(5):474-7. PubMed ID: 3117905
    [Abstract] [Full Text] [Related]

  • 7. Functional involvement of urokinase-type plasminogen activator receptor in pemphigus acantholysis.
    Xue W, Hashimoto K, Toi Y.
    J Cutan Pathol; 1998 Oct; 25(9):469-74. PubMed ID: 9821076
    [Abstract] [Full Text] [Related]

  • 8. [The role of urokinase-type plasminogen activator in the pathogenesis of pemphigus].
    Nie Z, Liu R, Ye Q.
    Zhonghua Yi Xue Za Zhi; 1997 Oct; 77(10):771-3. PubMed ID: 9772525
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E, Yamamoto Y, Aoyama Y, Kitajima Y.
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proteinase inhibitors block formation of pemphigus acantholysis in experimental models of neonatal mice and skin explants: effects of synthetic and plasma proteinase inhibitors on pemphigus acantholysis.
    Naito K, Morioka S, Nakajima S, Ogawa H.
    J Invest Dermatol; 1989 Jul; 93(1):173-7. PubMed ID: 2526184
    [Abstract] [Full Text] [Related]

  • 13. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
    Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y.
    J Dermatol Sci; 2007 Aug; 47(2):119-25. PubMed ID: 17532189
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apoptosis in pemphigus.
    Schmidt E, Waschke J.
    Autoimmun Rev; 2009 Jun; 8(7):533-7. PubMed ID: 19189866
    [Abstract] [Full Text] [Related]

  • 16. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis.
    Grando SA, Bystryn JC, Chernyavsky AI, Frusić-Zlotkin M, Gniadecki R, Lotti R, Milner Y, Pittelkow MR, Pincelli C.
    Exp Dermatol; 2009 Sep; 18(9):764-70. PubMed ID: 19555352
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris.
    Gil MP, Modol T, España A, López-Zabalza MJ.
    Exp Dermatol; 2012 Apr; 21(4):254-9. PubMed ID: 22320676
    [Abstract] [Full Text] [Related]

  • 18. The interaction of pemphigus autoimmunoglobulins with epidermal cells: activation of the fas apoptotic pathway and the use of caspase activity for pathogenicity tests of pemphigus patients.
    Frusic-Zlotkin M, Pergamentz R, Michel B, David M, Mimouni D, Brégégère F, Milner Y.
    Ann N Y Acad Sci; 2005 Jun; 1050():371-9. PubMed ID: 16014554
    [Abstract] [Full Text] [Related]

  • 19. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor.
    Hashimoto K, Wun TC, Baird J, Lazarus GS, Jensen PJ.
    J Invest Dermatol; 1989 Mar; 92(3):310-4. PubMed ID: 2465356
    [Abstract] [Full Text] [Related]

  • 20. Phosphatidylinositol-specific-phospholipase C cleaves urokinase plasminogen activator receptor from the cell surface and leads to inhibition of pemphigus-IgG-induced acantholysis in DJM-1 cells, a squamous cell carcinoma line.
    Asano S, Seishima M, Kitajima Y.
    Clin Exp Dermatol; 2001 May; 26(3):289-95. PubMed ID: 11422178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.